By Professor Sallie Pearson

Conference Papers

Shaw T; Rankin N; McGregor D; White K; Phillips J; Butow P; Young J; Trevena L; Pearson S; York S, 2014, 'A SYSTEMATIC APPROACH TO CLOSING EVIDENCE GAPS IN CANCER CARE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S-A, 2014, 'BIG DATA LINKAGES: THE MAGIC BULLET FOR CANCER HEALTH SERVICE RESEARCH?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reeve R; Srasuebkul P; Pearson S; Viney R; Haas M, 2014, 'COSTS OF CANCER CARE AT THE END OF LIFE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pace J; Pearson S; Lipworth W, 2014, 'LEGITIMACY OF FUNDING DECISIONS FOR CANCER MEDICINES: A THEMATIC ANALYSIS OF STAKEHOLDER PERSPECTIVES', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Srasuebkul P; Reeve R; Viney R; Haas M; Pearson S, 2014, 'RESOURCE USE IN THE LAST 180 DAYS OF LIFE IN THE ELDERLY DECENDENTS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 39 - +, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100107&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris C; Daniels B; Ward R; Pearson S-A, 2014, 'Do Pharmaceutical Claims Accurately Reflect Oncology Prescribing Practice: Evidence from an Australian HER2+Early Breast Cancer Cohort (HER2EBC)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 465 - 466, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600858&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris C; Pearson S-A; Daniels B; Ward R, 2014, 'HER2 Positive Early Breast Cancer (HER2EBC): An Australian Patterns of Care Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 468 - 468, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600863&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gnjidic D; Pearson S-A; Hilmer S; Basilakis J; Blyth F; Banks E, 2014, 'Manual Versus Automated Coding of Free-Text Self-Reported Drug Use in the 45 and Up Study: A Validation Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 143 - 144, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600270&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Leung C; Hilmer S; Pearson S-A; Gnjidic D, 2014, 'Temporal Changes in Polypharmacy, Hyperpolypharmacy and Exposure to Anticholinergic and Sedative Drugs: A Five-Year Study of Community-Dwelling Older Men', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 119 - 119, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600221&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Blanch B; Pearson SA; Haber PS, 2014, 'An overview of the patterns of prescription opioid use, costs and related harms in Australia', in British Journal of Clinical Pharmacology, pp. 1159 - 1166, http://dx.doi.org/10.1111/bcp.12446

Harris CA; Ward RL; Daniels B; Pearson S, 2013, 'Do pharmaceutical claims accurately reflect oncology prescribing practice? Evidence from an Australian HER2+early breast cancer cohort ( HER2EBC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Diego, presented at ASCO's Quality Care Symposium, CA, San Diego, 01 November 2013 - 02 November 2013, http://dx.doi.org/10.1200/jco.2013.31.31_suppl.100

Harris CA; Pearson S; Daniels B; Srasuebkul P; Ward RL, 2013, 'HER2-positive early breast cancer (HER2EBC): An Australian pattern of care study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Diego, presented at ASCO's Quality Care Symposium, CA, San Diego, 01 November 2013 - 02 November 2013, http://dx.doi.org/10.1200/jco.2013.31.31_suppl.101

Langton JM; Blanch B; Drew A; Haas M; Ingham JM; Pearson S, 2013, 'Resource utilization, costs, and quality of end-of-life cancer care: A systematic review of retrospective cohort studies based on routinely collected data (1990-2011)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Diego, presented at ASCO's Quality Care Symposium, CA, San Diego, 01 November 2013 - 02 November 2013, http://dx.doi.org/10.1200/jco.2013.31.31_suppl.111

Ganda K; Seibel M; Schaffer A; Pearson S, 2013, 'Adherence to Oral Bisphosphonate Therapy in a Fracture Liaison Service: A Randomised Controlled Trial', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY-BLACKWELL, MD, Baltimore, presented at Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, MD, Baltimore, 04 October 2013 - 07 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000332035804007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S-A; Abrahamowicz M; Srasuebkul P; Buckley N, 2013, 'Antidepressant Treatment (ADT) Following a Cancer Diagnosis: Investigation in a Cohort of Older Patients', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 199 - 199, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876100384&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S-A; Srasuebkul P; Lu C; Dobbins T; Ward R, 2011, 'The Impact of Evidence-Based Subsidy Restrictions on Lapatinib Use and Outcomes', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. S77 - S77, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294946600172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stavrou EP; Lu CY; Pearson S-A, 2011, 'The Role of Comorbidity in the Uptake of Chemotherapy and Cancer Survival', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. S279 - S280, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294946600618&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S; Srasuebkul P; Harris C; Ward RL; Dobbins TA; Harris C, 2010, 'Trastuzumab treatment outcomes according to concomitant chemotheray regimen: Overall survival of HER2+ metastatic breast cancer patients', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S187 - S187, presented at Pharmacoepidemiology & Therapeutic Risk Management, Brighton, UK, 19 August 2010 - 22 August 2010, http://dx.doi.org/10.1002/pds

Pearson S; Chin M; Ward RL, 2009, 'The Financially Tolerable Dose: A New Concept in Cancer Trial Design', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S173 - S174

Pearson S; Ringland C; Ward RL, 2008, 'Off-label trastuzumab use in Australia: Evidence from the national Herceptin Program for HER-2 positive metastatic breast cancer', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. 66 - 66, presented at Pharmacoepidemiology and Drug Safety

Ringland C; Pearson S; Ward RL, 2008, 'Survival of women treated with trastuzumab for HER-2-positive metastatic breast cancer: Estimating outcomes in clinical practice using administrative data', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. 436 - 437, presented at Pharmacoepidemiology and Drug Safety

Back to profile page